Condition
Breast Cancer Recurrent clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Breast Cancer Recurrent clinical trials that are recruiting, at sites in 12 countries (most in United States (3), Norway (1), United Kingdom (1)). By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 12Countries
Newest Breast Cancer Recurrent clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Testing ATX-295 for advanced solid tumors and ovarian cancer | Phase 1/2 | Aurora, Colorado and 10 other locations | Recruiting | Jan 29, 2025 |
| Adding superficial heat therapy (wIRA) to standard palliative radiotherapy | — | London and 1 other locations | Recruiting | Oct 26, 2024 |
| Using 18F-FDG PET/CT imaging to detect breast cancer metastases | — | Drammen | Recruiting | Feb 16, 2023 |
| Re-irradiation for breast cancer using a short radiation course | — | New York, New York and 18 other locations | Recruiting | Oct 25, 2022 |
| Using Functional Precision Oncology to Manage Early Metastatic Breast Cancer | Phase 2 | Salt Lake City, Utah | Recruiting | Jul 19, 2022 |
All recruiting trials (5)
-
Testing ATX-295 for advanced solid tumors and ovarian cancer
This study is testing a new oral medication called ATX-295 to see if it is safe and effective for people with advanced solid tumors, including ovarian cancer.
-
Adding superficial heat therapy (wIRA) to standard palliative radiotherapy
This project will test whether adding superficial hyperthermia (wIRA) to standard palliative radiotherapy helps control superficial tumours in adults with inoperable or recurrent head and neck, cutaneous, or recurrent breast cancers.
-
Using 18F-FDG PET/CT imaging to detect breast cancer metastases
This study is testing if a special type of imaging called 18F-FDG PET/CT can help find hidden breast cancer spread in patients with more advanced stages of the disease to see if it can change their treatment plans and improve their outcomes.
-
Re-irradiation for breast cancer using a short radiation course
This study is testing a shorter, one-week radiation treatment for women with recurring breast cancer to see if it is safer and leads to better results than the usual longer treatments.
-
Using Functional Precision Oncology to Manage Early Metastatic Breast Cancer
This study is testing a new approach to help patients with early-stage hormone receptor-low or triple negative breast cancer by using personalized models to predict and prevent cancer from coming back.
Related topics
Quick answers
How many Breast Cancer Recurrent clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in United States (3 trials), Norway (1 trial), United Kingdom (1 trial), Australia (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.